Current Cardiovascular Risk Reports最新文献_第7页

Unintentional Weight Loss as a Marker of Malignancy Across Body Weight Categories 非故意体重减轻是体重类别中恶性肿瘤的标志

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-06-03 DOI: 10.1007/s12170-021-00674-8

J. Hue, Kelsey E Ufholz, J. Winter, S. Markt

引用次数: 0

Risk Factor Management in Atrial Fibrillation: How to Deliver a Successful Clinic 房颤的危险因素管理:如何提供一个成功的诊所

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-05-27 DOI: 10.1007/s12170-021-00671-x

C. Gallagher, J. Fitzgerald, M. Stokes, J. Noubiap, A. Elliott, J. Hendriks, M. Middeldorp, P. Sanders, D. Lau

引用次数: 2

Racial and Ethnic Disparities in Transthyretin Cardiac Amyloidosis 转甲状腺素心脏淀粉样变性的种族和民族差异

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-04-04 DOI: 10.1007/s12170-021-00670-y

Gabriela Spencer‐Bonilla, Joyce N. Njoroge, K. Pearson, R. Witteles, M. Aras, K. Alexander

引用次数: 7

Arrhythmogenic Cardiomyopathy: Mechanisms, Genetics, and Their Clinical Implications 心律失常性心肌病:机制、遗传学及其临床意义

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-03-26 DOI: 10.1007/s12170-021-00669-5

C. Reuter, Annika M. Dries, V. Parikh

引用次数: 2

Methods to Optimize Cryoballoon Ablation for Atrial Fibrillation to Minimize Risk of Adverse Outcomes and Arrhythmia Recurrences 优化心房颤动冷冻球囊消融的方法，以最大限度地降低不良结果和心律失常复发的风险

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-03-13 DOI: 10.1007/s12170-021-00668-6

J. Andrade

引用次数: 0

Novel Approaches to Risk Stratification of In-Hospital Cardiac Arrest 院内心脏骤停风险分层的新方法

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-01-31 DOI: 10.1007/s12170-021-00667-7

Jason J Yang, Xiao Hu, N. Boyle, Duc H. Do

引用次数: 1

Novel Approaches to Risk Assessment for Ventricular Tachycardia Induction and Therapy 室性心动过速诱发和治疗风险评估的新方法

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-01-11 DOI: 10.1007/s12170-020-00666-0

Yuki Ishidoya, R. Ranjan

引用次数: 0

Novel Digital Technologies for Blood Pressure Monitoring and Hypertension Management. 血压监测和高血压管理的新型数字技术。

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-01-01 DOI: 10.1007/s12170-021-00672-w

Allison J Hare, Neel Chokshi, Srinath Adusumalli

{"title":"Novel Digital Technologies for Blood Pressure Monitoring and Hypertension Management.","authors":"Allison J Hare, Neel Chokshi, Srinath Adusumalli","doi":"10.1007/s12170-021-00672-w","DOIUrl":"https://doi.org/10.1007/s12170-021-00672-w","url":null,"abstract":"Purpose of review: Hypertension is common, impacting an estimated 108 million US adults, and deadly, responsible for the deaths of one in six adults annually. Optimal management includes frequent blood pressure monitoring and antihypertensive medication titration, but in the traditional office-based care delivery model, patients have their blood pressure measured only intermittently and in a way that is subject to misdiagnosis with white coat or masked hypertension. There is a growing opportunity to leverage our expanding repository of digital technology to reimagine hypertension care delivery. This paper reviews existing and emerging digital tools available for hypertension management, as well as behavioral economic insights that could supercharge their impact.Recent findings: Digitally connected blood pressure monitors offer an alternative to office-based blood pressure monitoring. A number of cuffless blood pressure monitors are in development but require further validation before they can be deployed for widespread clinical use. Patient-facing hubs and applications offer a means to transmit blood pressure data to clinicians. Though artificial intelligence could allow for curation of this data, its clinical use for hypertension remains limited to assessing risk factors at this time. Finally, text-based and telemedicine platforms are increasingly being employed to translate hypertension data into clinical outcomes with promising results.Summary: The digital management of hypertension shows potential as an avenue for increasing patient engagement and improving clinical efficiency and outcomes. It is important for clinicians to understand the benefits, limitations, and future directions of digital health to optimize management of hypertension.","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"15 8","pages":"11"},"PeriodicalIF":1.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s12170-021-00672-w","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10651630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

"Can you see my screen?" Addressing Racial and Ethnic Disparities in Telehealth. “你能看到我的屏幕吗?”消除远程保健中的种族和族裔差异。

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-01-01 Epub Date: 2021-12-06 DOI: 10.1007/s12170-021-00685-5

Norrisa Haynes, Agnes Ezekwesili, Kathryn Nunes, Edvard Gumbs, Monique Haynes, JaBaris Swain

{"title":"\"Can you see my screen?\" Addressing Racial and Ethnic Disparities in Telehealth.","authors":"Norrisa Haynes, Agnes Ezekwesili, Kathryn Nunes, Edvard Gumbs, Monique Haynes, JaBaris Swain","doi":"10.1007/s12170-021-00685-5","DOIUrl":"https://doi.org/10.1007/s12170-021-00685-5","url":null,"abstract":"Purpose of review: Telehealth is an innovative approach with great potential to bridge the healthcare delivery gap, especially for underserved communities. While minority populations represent a target audience that could benefit significantly from this modern solution, little of the existing literature speaks to its acceptability, accessibility, and overall effectiveness in underserved populations. Here, we review the various challenges and achievements of contemporary telehealth and explore its impact on care delivery as an alternative or adjunct to traditional healthcare delivery systems.Recent findings: Given the COVID-19 pandemic, there has been a rapid acceleration in telemedicine adoption. Recent studies of telemedicine utilization during the pandemic reveal stark disparities in telemedicine modality use based on race, socioeconomic status, geography, and age.Summary: While telehealth has great potential to overcome healthcare obstacles, the digital divide stands as a challenge to equitable telehealth and telemedicine adoption. Achieving health equity in telehealth will require the mobilization of resources, financial incentives, and political will among hospital systems, insurance companies, and government officials.","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"15 12","pages":"23"},"PeriodicalIF":1.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647517/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39720974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 29

Management of Pulmonary Arterial Hypertension. 肺动脉高压的处理。

IF 1.9

Current Cardiovascular Risk Reports Pub Date : 2021-01-01 Epub Date: 2020-11-18 DOI: 10.1007/s12170-020-00663-3

Jennalyn D Mayeux, Irene Z Pan, John Dechand, Joshua A Jacobs, Tara L Jones, Stephen H McKellar, Emily Beck, Nathan D Hatton, John J Ryan

{"title":"Management of Pulmonary Arterial Hypertension.","authors":"Jennalyn D Mayeux, Irene Z Pan, John Dechand, Joshua A Jacobs, Tara L Jones, Stephen H McKellar, Emily Beck, Nathan D Hatton, John J Ryan","doi":"10.1007/s12170-020-00663-3","DOIUrl":"https://doi.org/10.1007/s12170-020-00663-3","url":null,"abstract":"Purpose of review: This review focuses on the therapeutic management and individualized approach to Group 1 pulmonary arterial hypertension (PAH), utilizing Food and Drug Administration-approved PAH-specific therapies and various interventional and surgical options for PAH.Recent findings: The paradigm for the optimal management of PAH has shifted in recent years. Upfront combination therapy with an endothelin receptor antagonist and a phosphodiesterase 5 inhibitor is now widely accepted as standard of care. In addition, there is increasing emphasis on starting prostanoids early in order to delay time to clinical worsening. However, less is known regarding which prostanoid agent to initiate and the optimum time to do so. In order to facilitate shared decision-making, there is an increasing need for decision tools based on guidelines and collective clinical experiences to navigate between pharmacologic and interventional treatments, as well as explore innovative, therapeutic pathways for PAH.Summary: The management of PAH has become increasingly complex. With a growing number of PAH-specific therapies, intimate knowledge of the therapeutics and the potential barriers to adherence are integral to providing optimal care for this high-risk patient population. While current PAH-specific therapies largely mediate their effects through pulmonary vasodilation, ongoing research efforts are focused on ways to disrupt the mechanisms leading to pulmonary vascular remodeling. By targeting aberrations identified in the metabolism and proliferative state of pulmonary vascular cells, novel PAH treatment pathways may be just on the horizon.","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"15 1","pages":"2"},"PeriodicalIF":1.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s12170-020-00663-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38631485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 27